Regenics vs IVIM Health: Compounded GLP-1 options compared
Regenics vs IVIM Health: both are telehealth platforms prescribing compounded GLP-1 medications, but they differ on pricing structure, clinical claims, clinician model, patient satisfaction signals, and program features. Early verdict: choose Regenics for the lowest advertised first-month price and a Sermorelin add-on; choose IVIM Health for stronger third-party ratings, a free consultation, and a structured protocol claim.
Start Regenics from $139 first month
How Regenics and IVIM Health compare at a glance
| Criteria | Regenics | IVIM Health |
|---|---|---|
| Starting price | Semaglutide $139 first month; tirzepatide $189 first month | Semaglutide $75/mo listed; promotional references and program fees apply |
| Ongoing price notes | Semaglutide renews $199/mo; tirzepatide renews $279/mo | Lists $99 first month and $174/month ongoing; also cites $74.99/mo program fee in some materials |
| Clinical model | Licensed nurse practitioners review intake and oversee prescriptions | Licensed clinicians provide a no-obligation free consult and clinician-guided GLP-1 ID protocol |
| Third-party validation | No third-party rating cited | 4.9-star rating on both Google and Trustpilot cited |
| Regulatory note | Compounded medications are not FDA-approved finished products | Compounded medications are not FDA-approved and have not undergone FDA review |
Price and promotional structure
Price is a clear differentiator in the Regenics vs IVIM Health comparison. Regenics advertises semaglutide starting at $139 first month and tirzepatide at $189 first month, with stated renewals of $199 and $279 respectively. IVIM Health advertises lower listed monthly figures in some captured materials, including semaglutide at $75/mo and tirzepatide at $133/mo, but also publishes a $99 first month and $174/month ongoing rate in FAQs and mentions a $74.99/mo program fee in some messaging. Regenics notes promotional pricing applies to the first month only; IVIM also shows promotional codes such as GIFT75 for a free month membership.
Get IVIM Health free consult and GIFT75 code
Clinical oversight and program features
Both providers require clinician review before prescribing compounded GLP-1s, but they emphasize different clinician models. Regenics describes nurse-practitioner-led care and says licensed nurse practitioners oversee every prescription. IVIM Health frames care as clinician-guided and highlights a no-obligation free consultation valued at $75 for new patients. IVIM also promotes a proprietary GLP-1 ID protocol that it says may accelerate results, while Regenics highlights the availability of a Sermorelin peptide add-on for recovery and muscle support.
See Regenics nurse-practitioner care
Evidence, satisfaction, and claimed outcomes
IVIM Health emphasizes unusually strong third-party satisfaction signals, citing 4.9-star ratings on both Google and Trustpilot and internal study findings that IVIM patients following their protocol lost an average of 46% more weight over 68 weeks compared to a published GLP-1 trial. The comparison materials note that those studies are not head-to-head trials and that the 40% faster claim for GLP-1 ID is a proprietary protocol claim. Regenics does not present third-party rating claims in the supplied evidence but positions itself as a straightforward, mid-pack priced telehealth option with compounded semaglutide and tirzepatide and a LegitScript certified pharmacy network mentioned in longer descriptions.
Regulatory and safety notes to consider
Both providers make clear that the medications offered are compounded and are not FDA-approved as finished products. Regenics explicitly states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. IVIM Health repeats the regulatory caution and notes compounded drugs have not undergone FDA review for safety, efficacy, or quality and may not be available in all states. Both require clinician evaluation before prescribing.
Direct comparison summary
- Pricing: Regenics advertises the lowest first-month price for semaglutide at $139 first month; IVIM markets promotional options and a free-month code with ongoing pricing that appears in materials as $174/month.
- Clinician model: Regenics is nurse-practitioner-led; IVIM offers clinician consultations and a proprietary GLP-1 ID protocol.
- Third-party trust: IVIM reports 4.9-star ratings on Google and Trustpilot; Regenics does not list third-party star ratings in the supplied evidence.
- Program extras: Regenics offers Sermorelin peptide therapy; IVIM emphasizes structured protocol and published retrospective studies tied to its program.
- Regulatory caution: Both repeat that compounded medications are not FDA-approved finished products.
Choose Regenics if…
you prioritize a lower advertised first-month price (semaglutide $139 first month; tirzepatide $189 first month), want nurse-practitioner-led telehealth care, and value an offered Sermorelin peptide add-on. Treatment is subject to clinician review and compounded medications are not FDA-approved.
Start IVIM Health free consult
Choose IVIM Health if…
you value strong third-party satisfaction signals (4.9 stars on Google and Trustpilot noted in supplied materials), want a no-obligation free consultation for new patients, and are interested in IVIM’s clinician-guided GLP-1 ID protocol and related published retrospective outcome studies. IVIM materials also reference promotional codes such as GIFT75 for a free month membership. Compounded medications are not FDA-approved and are prescribed only after clinical evaluation.
Compare Regenics options and start intake
Regenics vs IVIM Health: both offer clinician-supervised access to compounded GLP-1s with distinct tradeoffs in first-month pricing, clinician presentation, program structure, and third-party ratings. Review the regulatory notes and clinician requirements from each provider before deciding.